Goldman Sachs Reinstates Shanghai Pharmaceuticals Holdings (2607:HK) (FJLLF) at Neutral

April 16, 2021 11:37 AM EDT
Get Alerts 2607:HK Hot Sheet
Price: $0.00 --0%

Rating Summary:
    0 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 19 | Down: 13 | New: 24
Trade Now! 
Join SI Premium – FREE

Goldman Sachs analyst Ziyi Chen reinstates coverage on Shanghai Pharmaceuticals Holdings (2607:HK) (OTC: FJLLF) with a Neutral rating and a price target of HK$15.60.

You May Also Be Interested In

Related Categories

Intl Ratings, New Coverage